Upcoming Webinar
Multiple Myeloma: Opportunities and Challenges in the Changing Treatment Landscape
Healthcare11/15/2024 2:00 PM
Description
In this webinar, you will get to know:
The latest treatment paradigms for first-line therapy in transplant-eligible patients
Evolving strategies for first-line therapy in transplant-ineligible patients
Second-line treatment breakthroughs, including the resurgence of Belantamab Mafodotin
Innovative endpoints in the design of multiple myeloma clinical trials
Key opportunities and challenges in managing relapse and refractory disease
Speaker: Dr. Stavros Gkolfinopoulos - Associate Director, Global Safety Physician.
Comments
Publisher
Veeda Clinical Research Limited ("Veeda"), together with its subsidiary, Bioneeds India Private Limited ("Bioneeds"), offers a comprehensive portfolio of clinical, preclinical, and bio/analytical services to support innovator, biosimilar, and generic drug development programs. Veeda is an independent, institutional investor-owned, board-governed, and professionally managed contract research group. We provide scientific leadership, global quality management systems, and long-term operational and financial stability. Our services cater to industries such as pharmaceutical and biopharmaceutical, agrochemical and industrial chemicals, herbal/nutraceuticals, and medical devices. We strive to deliver scientific excellence through safe and quality research solutions with no compromise on ethical practices. Our mission is to enable healthcare's ambition of longer, healthier, and happier lives by supporting diverse drug development programs through comprehensive service capabilities.